Skip to main content

Table 1 Clinicopathological characteristics and SPOP methylation in 82 NSCLC patients

From: Speckle-type POZ protein functions as a tumor suppressor in non-small cell lung cancer due to DNA methylation

Clinicopathological characteristics

Number (n = 82)

SPOP methylation

P

Methylated (n = 33)

Partial methylation (n = 28)

Unmethylated (n = 21)

Age (years)

0.448

 ≤ 60

44

15

16

13

 > 60

38

18

12

8

Gender

0.416

 Male

48

22

14

12

 Female

34

11

14

9

Histologic type

0.086

 Adenocarcinoma

63

29

21

13

 Squamous cell carcinoma

19

4

7

8

Smoking status

0.064

 Ever

34

9

16

9

 Never

48

24

12

12

Staging

0.903

 I + II

60

25

20

15

 III + IV

22

8

8

6

Pathology grade

0.018*

 Well

14

3

2

9

 Moderate

43

20

15

8

 Poor

25

10

11

4

Lymph node metastasis

0.094

 No

45

23

13

9

 Yes

37

10

15

12

  1. * Indicates statistically significant difference